"The Mechanic" Cellular Energy Optimization Protocol

Your cells run on a molecule called ATP, which is essentially a rechargeable battery that powers every process in your body, and the factory that makes most of it is the mitochondria. Inside that factory, there is an assembly line called the electron transport chain, where electrons get passed from one protein complex to the next, and the energy released from those transfers gets used to pump protons across the inner mitochondrial membrane, and that proton gradient is what actually drives ATP production. That whole process works beautifully when you are young and the system is intact.

As you age, three separate things start breaking down at once.

The first is structural. The inner mitochondrial membrane contains a special phospholipid called cardiolipin, which holds the protein complexes of the electron transport chain in the right shape and position. When cardiolipin gets oxidized or damaged, those complexes shift and electrons start leaking out before they finish the chain, which means instead of making ATP, you are generating reactive oxygen species that damage the membrane further. It is a self-reinforcing failure loop.

The second is metabolic. Your cells use NAD+ to run the electron transport chain in the first place, and NAD+ levels drop significantly with age, partly because of an enzyme called CD38, which degrades NAD+ as a byproduct of its normal immune signaling function. Research has shown that CD38 activity increases two to three fold with age, and there is a compounding mechanism underneath that: senescent cells, which are damaged cells that refuse to die and accumulate in your tissues over time, secrete inflammatory signals that cause immune cells called macrophages to upregulate CD38. So the more senescent cells you accumulate, the more CD38 activity you get, and the faster your NAD+ gets consumed.

The third is simply that the machinery becomes less efficient at extracting energy from what fuel is available.

That is the full picture. Now the protocol maps onto that picture layer by layer.

The foundation layer is not glamorous but it is doing real work. Creatine at five grams per day supports the phosphocreatine system, which is a fast ATP recycling pathway your cells use when demand spikes before the mitochondria can ramp up. CoQ10, which is a molecule that carries electrons between Complex I and Complex III in the electron transport chain, declines meaningfully with age, and without adequate CoQ10 the chain slows down even when everything else is intact.

The repair phase addresses the structural problem first because it does not make sense to try to optimize a broken system.

SS-31 is a small peptide that binds directly to cardiolipin on the inner mitochondrial membrane. What is notable about that binding is not just stabilization in the abstract but that it physically maintains the folded structure of the membrane, called cristae, which is where the electron transport chain complexes are housed. When SS-31 stabilizes cardiolipin, electron leakage drops, which means less reactive oxygen species and more electrons actually completing the chain to produce ATP. The conservative dosing of one to two milligrams per day for four to eight weeks gives the membrane time to stabilize before you push harder.

While the mitochondria are being stabilized, the senescent cell burden is addressed with FOXO4-DRI. Here is how that works. Senescent cells are supposed to die through a process called apoptosis, but they avoid it by forming a complex between two proteins, FOXO4 and p53, which keeps p53 trapped and inactive. FOXO4-DRI is a peptide that competes with that complex and frees p53, which then triggers apoptosis specifically in the senescent cells. In published research, this selectivity was measured at 11.73-fold, meaning senescent cells died at nearly twelve times the rate of healthy cells at the same dose. You will feel this working because clearing those cells creates a brief inflammatory signal as the immune system processes the debris, and that is expected and temporary.

Epithalon comes in at the end of the repair phase, one to two times per year for ten to twenty days at a time. Its primary studied mechanism involves telomerase activation, which is the enzyme that maintains the protective caps on chromosomes, and research in human fibroblasts showed it induced both telomerase activity and measurable telomere elongation. It also appears to restore some pineal gland signaling, which affects melatonin and downstream repair processes. This is used sparingly because you are not trying to run it continuously, you are giving the system a periodic restoration signal.

Once the structural repair is done, the optimize phase shifts the goal from fixing to performing.

MOTS-c is a peptide that is actually encoded within the mitochondrial genome itself, which is unusual since most proteins are encoded in the nuclear genome, and it activates something called AMPK, which is a master metabolic regulator that essentially tells cells to become more efficient energy producers. When MOTS-c was given to mice in research settings, it prevented diet-induced obesity and insulin resistance even without changes in food intake, and the mechanism ran through AMPK activation via the folate cycle inside the cell. At five to fifteen milligrams per week split across three injections, you are using a physiological signal to push mitochondria that have already been structurally repaired to actually perform better.

The question that usually comes up here is about NAD+ supplementation, specifically NMN or NR, and the honest answer is more nuanced than the marketing suggests. Research published in 2025 found that most oral NMN and NR gets converted to niacin-pathway metabolites in the gut before absorption anyway, which means the cells are largely using the same biosynthesis pathway they would use if you just took niacin. Niacin costs pennies per dose. If you want injectable NAD+ and can afford it, the direct delivery bypasses that conversion step entirely, which is the legitimate argument for it.

L-carnitine as an optional add-on has a specific and well-defined function: it is the molecule responsible for transporting long-chain fatty acids across the inner mitochondrial membrane so they can be burned for energy. That transport cannot happen without it. Supplemental L-carnitine at 200 to 500 milligrams three to five times per week supports that transport capacity, which matters most when fat oxidation is a priority.

One mechanism worth understanding across this entire protocol is why exercise still matters so much within it. NAMPT is the enzyme your body uses to produce NAD+ from precursors, and in one study, sedentary subjects who began exercise training showed a 127 percent increase in skeletal muscle NAMPT protein. Exercise is not just burning calories. It is upregulating the machinery that produces the very molecule this entire protocol is trying to support. The supplements work in the context of that upregulation, not instead of it.

The thing most people get backwards about cellular energy is that they imagine the problem is a deficiency of any single molecule, so they chase that molecule. But what the research actually shows is a cascade: structural damage leads to inefficiency, which leads to reactive oxygen species, which leads to more damage, and senescent cells accelerate NAD+ depletion on top of that, which limits the electron transport chain's ability to run at all. You are not deficient in one thing. The system has degraded in sequence. Which means the protocol that actually works addresses each layer in sequence too, foundation first, then repair, then optimization. Everything else is just adding inputs to a machine that is still broken.

---

References

1. Birk AV, Liu S, Soong Y, et al. The Mitochondrial-Targeted Compound SS-31 Re-Energizes Ischemic Mitochondria by Interacting with Cardiolipin. Journal of the American Society of Nephrology. 2013;248:1250-1261. Finding: SS-31 selectively binds cardiolipin on the inner mitochondrial membrane, stabilizing cristae structure. Source
2. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. British Journal of Pharmacology. 2014;1718:2029-2050. Finding: SS-31 binds cardiolipin, stabilizes mitochondrial membrane structure, and reduces electron leakage and ROS production. Source
3. Baar MP, Brandt RMC, Putavet DA, et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017;1691:132-147. Finding: FOXO4-DRI disrupts FOXO4-p53 interaction in senescent cells, freeing p53 to trigger apoptosis. 11.73-fold selectivity for senescent vs healthy cells. Source
4. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 2016;236:1127-1139. Finding: CD38 activity increases 2-3 fold with age. CD38 knockout mice maintained NAD+ levels at all ages. Source
5. Covarrubias AJ, Kale A, Perrone R, et al. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. Nature Metabolism. 2020;211:1265-1283. Finding: Senescent cell SASP cytokines induce macrophages to upregulate CD38, establishing the causal chain from senescence to NAD+ decline. Source
6. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine. 2003;1356:590-592. Finding: Epithalon induced hTERT expression, telomerase activity, and telomere elongation in human fibroblasts. Source
7. Goncharova ND, Vengerin AA, Khavinson VKh, Lapin BA. Pineal peptides restore the age-related disturbances in hormonal functions of the pineal gland and the pancreas. Experimental Gerontology. 2005;401-2:51-57. Finding: Epithalamin at 5mg/day and synthetic Epithalon at 10mcg/day achieved equivalent melatonin restoration in aged monkeys, demonstrating 500-fold potency difference. Source
8. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;213:443-454. Finding: MOTS-c activates AMPK via inhibition of the folate cycle. Prevented insulin resistance and diet-induced obesity. Source
9. Shats I, Williams JG, Liu J, et al. Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway. Cell Metabolism. 2020;313:564-579. Finding: Gut bacteria deamidate nicotinamide to nicotinic acid niacin, confirming NMN/NR undergo gut conversion before absorption. Source
10. Kim LJ, et al. Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation. Science Advances. 2025. Finding: Most oral NMN and NR is converted to niacin-pathway metabolites in the gut before absorption. Source
11. Costford SR, Bajpeyi S, Pasarica M, et al. Skeletal muscle NAMPT is induced by exercise in humans. American Journal of Physiology - Endocrinology and Metabolism. 2010;2981:E117-E126. Finding: NAMPT protein increased 127% in sedentary subjects after exercise training. Source
12. Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochimica et Biophysica Acta. 2016;186310:2422-2435. Finding: L-carnitine is the sole molecule carrying long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation. Source
13. Banerjee R, Purhonen J, Bhardwaj R, Bhargava A, Kallijarvi J. The mitochondrial coenzyme Q junction and complex III. The FEBS Journal. 2022;28922:6936-6958. Finding: CoQ serves as the mobile electron carrier between Complex I/II and Complex III. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness